Prostate Cancer Reports


Volume 3 Supplement 6
June 2015

Home > Prostate Cancer Reports > Volume 3, Year 2015 > Supplement 6, June


CONTENTS



PROGNOSIS AND OUTCOMES





PROGNOSIS AND OUTCOMES



Prediction of biochemical recurrence after radical prostatectomy


Stamey TA, Yemoto CM, McNeal JE, Sigal BM, Johnstone IM.
Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens.
J Urol. 2000 Apr;163(4):1155-60.
Source | Abstract | Similar articles




Prediction of clinical recurrence after radical prostatectomy


Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.
Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
BJU Int. 2006 Jan;97(1):51-5. Epub 2005 Dec 6.
Source | Abstract | Full text | Similar articles




Prognostic impact of positive biopsy cores


Antunes AA, Dall'Oglio MF, Sant'Anna AC, Paranhos M, Leite KR, Srougi M.
Prognostic value of the percentage of positive fragments in biopsies from patients with localized prostate cancer.
Int Braz J Urol. 2005 Jan-Feb;31(1):34-41.
Source | Abstract | Full text | Similar articles




Capitanio U, Briganti A, Shariat SF, Karakiewicz PI.
The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspective.
Eur Urol. 2008 Oct;54(4):717-9. doi: 10.1016/j.eururo.2008.07.034. Epub 2008 Jul 21.
Source | Abstract | Full text | Similar articles




Freedland SJ, Terris MK, Csathy GS, Kane CJ, Amling CL, Presti JC Jr, Dorey F, Aronson WJ; Search Database Study Group.
Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen.
J Urol. 2004 Jun;171(6 Pt 1):2215-20.
Source | Abstract | Similar articles




Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC Jr.
The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Cancer. 2003 Dec 1;98(11):2344-50. Epub 2003 Oct 20.
Source | Abstract | Full text | Similar articles




Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC Jr; SEARCH Database Study Group.
Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
J Urol. 2003 Jun;169(6):2136-41.
Source | Abstract | Similar articles




Freedland SJ, Aronson WJ, Csathy GS, Kane CJ, Amling CL, Presti JC Jr, Dorey F, Terris MK; SEARCH Database Study Group.
Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database.
Urology. 2003 Apr;61(4):742-7.
Source | Abstract | Similar articles




Freedland SJ, Csathy GS, Dorey F, Aronson WJ.
Clinical utility of percent prostate needle biopsy tissue with cancer cutpoints to risk stratify patients before radical prostatectomy.
Urology. 2002 Jul;60(1):84-8.
Source | Abstract | Similar articles




Harnden P, Shelley MD, Naylor B, Coles B, Mason MD.
Does the extent of carcinoma in prostatic biopsies predict prostate-specific antigen recurrence? A systematic review.
Eur Urol. 2008 Oct;54(4):728-39. doi: 10.1016/j.eururo.2008.06.068. Epub 2008 Jun 26.
Source | Abstract | Full text | Similar articles




Valette TN, Antunes AA, Leite KM, Srougi M.
Probability of extraprostatic disease according to the percentage of positive biopsy cores in clinically localized prostate cancer.
Int Braz J Urol. 2015 May-Jun;41(3):449-54. doi: 10.1590/S1677-5538.IBJU.2014.0223.
Source | Abstract | Full text | Similar articles




Outcomes of men with an elevated PSA level as their sole preoperative risk feature


Faisal FA, Sundi D, Pierorazio PM, Ball MW, Humphreys EB, Han M, Epstein JI, Partin AW, Carter HB, Bivalacqua TJ, Schaeffer EM, Ross AE.
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
BJU Int. 2014 Dec;114(6b):E120-9. doi: 10.1111/bju.12771. Epub 2014 Aug 13.
Source | Abstract | Full text | Similar articles




Outcomes after robot-assisted radical prostatectomy


Sukumar S, Rogers CG, Trinh QD, Sammon J, Sood A, Stricker H, Peabody JO, Menon M, Diaz-Insua M.
Oncological outcomes after robot-assisted radical prostatectomy: long-term follow-up in 4803 patients.
BJU Int. 2014 Dec;114(6):824-31. doi: 10.1111/bju.12404.
Source | Abstract | Full text | Similar articles